AI stocks slide before the bell as Nvidia’s China push revives export jitters
21 January 2026
1 min read

AI stocks slide before the bell as Nvidia’s China push revives export jitters

New York, Jan 21, 2026, 06:47 EST — Premarket

Nvidia and other AI-related stocks dipped in Wednesday’s premarket session after Reuters reported that CEO Jensen Huang aims to visit China in late January. The move highlights ongoing uncertainties surrounding high-end chip sales to the country. Nvidia dropped 4.3% to $178.07, Broadcom slid 5.4% to $332.60, and Taiwan Semiconductor lost 4.4% to $327.16. Microsoft and Alphabet also saw declines. 1

The China factor is critical now since the AI boom hinges on a straightforward premise: more data centres, more chips, and increased spending. But policy tensions can quickly alter that spending trajectory, particularly when it comes to the priciest processors.

Timing is another factor. As big cloud and platform companies gear up to report soon, investors are zeroing in on forward guidance to gauge if AI spending is still strong or beginning to resemble last year’s over-ordering spree.

Last week, the Trump administration gave the green light to Nvidia’s H200 chip sales to China, though under strict rules requiring third-party testing and shipment conditions, Reuters reported. Seaport Research analyst Jay Goldberg dismissed the framework as “a Band-Aid,” while Saif Khan, a former White House National Security Council official, warned the rule would “substantially boost China’s AI capabilities.” 2

The policy change hasn’t cleared up the issue. Chinese customs officials informed agents that Nvidia’s H200 chips cannot be imported into China, Reuters reported. It remains uncertain if this is a formal ban or just a temporary restriction. 3

Nvidia is ramping up its focus on “inference” — the phase where a trained AI model delivers outputs like answers, images, or code based on prompts — shifting attention from just building models to scaling their operation. According to The Wall Street Journal, the company put $150 million into Baseten during a $300 million funding round that values the startup at $5 billion. 4

The export debate took center stage at Davos this week. Anthropic CEO Dario Amodei likened selling advanced AI chips to China to “selling nuclear weapons to North Korea,” in a chat with Bloomberg Editor-in-Chief John Micklethwait at the World Economic Forum. 5

Attention is shifting from chips to major AI investors. Microsoft plans to release its fiscal 2026 second-quarter earnings after the market closes on Wednesday, Jan. 28. 6

But policy risk works both ways. Washington’s easing can be pulled back, while Beijing might keep restrictions in place, throwing off investors’ sense of demand and supply simultaneously. Even setting politics aside, the downside is clear: AI spending rises, just not quickly enough to meet the high expectations already priced in.

Mark your calendar for Jan. 28, when Microsoft releases its earnings call, revealing new figures on cloud demand and AI spending — exactly the update traders have been waiting on. 7

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Natural gas price jumps again after Tuesday surge as Arctic cold tightens grip
Previous Story

Natural gas price jumps again after Tuesday surge as Arctic cold tightens grip

Mortgage rates today tick higher near 6% as Treasury yields bite again and housing stocks slip
Next Story

Mortgage rates today tick higher near 6% as Treasury yields bite again and housing stocks slip

Go toTop